S0400, FR901228 in Treating Patients With Advanced Cancer of the Urothelium

Summary

RATIONALE: Drugs used in chemotherapy, such as FR901228 (depsipeptide), work in different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: This phase II trial is studying how well FR901228 works in treating patients with advanced cancer of the urothelium that has progressed or recurred after receiving one chemotherapy regimen.

Timeline

Start

2004-06

Primary completion

2006-04

Completion

2006-04

Outcome

Outcome not reported

Stopped (Enrollment): “Permanently Closed Due to Poor Accrual”

Drugs

Indications